Custom gene synthesis and plasmid production
Ended Purchase Order Awarded
- Contract number
- 75N91022P00434
- Awardee
-
Epoch Life Science Inc. UEI FCX2ZB7YKNR8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,000
Award facts
- Opportunity
-
- NCCIH2022RT0003 Solicitation number
- Contract value 100% obligated
- $15,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sugar Land, TX 77496, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N91022P00434?
75N91022P00434 was awarded to Epoch Life Science Inc. by National Cancer Institute (National Institutes of Health) on May 9, 2022.
How much is contract 75N91022P00434 worth?
The government has obligated $15,000 on 75N91022P00434.
Was contract 75N91022P00434 competed?
The extent of competition for 75N91022P00434 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award